Prevalence of HCV infection and associated factors - SIGAA

Prevalence of HCV infection and associated factors - SIGAA

Revista da Sociedade Brasileira de Medicina Tropical
http://dx.doi.org/10.1590/0037-‐8682-‐0153-‐2013
Prevalence of HCV infection and associated factors among
illicit drug users in Breves, State of Pará, northern Brazil
Suzy Danielly Barbosa Pacheco[1], Gláucia Caroline Silva-‐Oliveira[1],[5],
Luciana Maria Cunha Maradei-‐Pereira[2], José Ângelo Barletta Crescente[3],
José Alexandre Rodrigues de Lemos[2],[4] and Aldemir Branco de Oliveira-‐Filho[2],[5]
>@)DFXOGDGHGH&LrQFLDV1DWXUDLV&DPSXVGR0DUDMy%UHYHV8QLYHUVLGDGH)HGHUDOGR3DUi%UHYHV3$>@&HQWURGH+HPDWRORJLDH+HPRWHUDSLDGR3DUi
%HOpP3$>@1~FOHRGH0HGLFLQD7URSLFDO8QLYHUVLGDGH)HGHUDOGR3DUi%HOpP3$>@,QVWLWXWRGH&LrQFLDV%LROyJLFDV8QLYHUVLGDGH)HGHUDOGR3DUi
Belém, PA. [5]. Instituto de Estudos Costeiros, Universidade Federal do Pará, Bragança, PA.
ABSTRACT
Introduction:,OOLFLWGUXJXVHUV'8VDUHYXOQHUDEOHWRKHSDWLWLV&YLUXV+&9LQIHFWLRQ7KHVKDUHGXVHRILOOLFLWGUXJVLVWKH
PDLQPHWKRGRI+&9WUDQVPLVVLRQMethods: A cross-­sectional study was conducted in Breves, in northern Brazil. We surveyed '8V WR GHWHUPLQH WKH SUHYDOHQFH RI DQG IDFWRUV DVVRFLDWHG ZLWK +&9 LQIHFWLRQ Results: 7KH SUHYDOHQFH RI DQWL+&9
DQWLERGLHVZDVDQGWKHSUHYDOHQFHRIKHSDWLWLV&YLUXVULERQXFOHLFDFLG+&951$ZDV+HSDWLWLV&YLUXVLQIHFWLRQ
ZDVDVVRFLDWHGZLWKWDWWRRVLQWUDYHQRXVGUXJXVHVKDUHGXVHRIHTXLSPHQWIRUGUXJXVHGUXJXVHIRUORQJHUWKDQ\HDUVDQG
daily drug use. Conclusions: 6WUDWHJLHVIRUSUHYHQWLQJDQGFRQWUROOLQJ+&9WUDQVPLVVLRQVKRXOGEHLPSOHPHQWHGDPRQJ'8V
Keywords:+HSDWLWLV&YLUXV,OOLFLWGUXJXVHUV1RUWKHUQ%UD]LO
&XUUHQWO\ WKH VKDULQJ RI GUXJ SDUDSKHUQDOLD LV WKH PDLQ
WUDQVPLVVLRQPHWKRGIRUKHSDWLWLV&YLUXV+&9ZRUOGZLGH
,W LV HVWLPDWHG WKDW PRUH WKDQ RI QHZ +&9 LQIHFWLRQ
FDVHVUHFRUGHGHDFK\HDUDUHUHODWHGWRWKHXVHRILOOLFLWGUXJV
SDUWLFXODUO\LQMHFWHGGUXJV1,2,Q%UD]LOHSLGHPLRORJLFDOVWXGLHV
RI+&9LQIHFWLRQLQLOOLFLWGUXJXVHUVDUHVWLOOUDUH7KHSUHYDOHQFH
RI+&9LQIHFWLRQLQLOOLFLWGUXJXVHUVVDPSOHGLQPHWURSROLWDQ
DUHDVLQWKH1RUWKHDVW0LGZHVW6RXWKDQG6RXWKHDVWUHJLRQV
RI%UD]LOUDQJHGIURPWR3-­77KHUHDUHIUHTXHQWUHSRUWV
RI FOLQLFDO FDVHV RI KHSDWLWLV RU SDWKRORJLHV DVVRFLDWHG ZLWK
+&9LQIHFWLRQLQRWKHUSRSXODWLRQJURXSVLQQRUWKHUQ%UD]LO8-­11. It is known that most illicit drug users in Pará do not consume LQMHFWHGGUXJVDQGDUHLQIHFWHGZLWK+&9JHQRW\SH10,117KLV
VWXG\HVWLPDWHGWKHSUHYDOHQFHRI+&9LQIHFWLRQDQGDVVHVVHG
WKHIDFWRUVDVVRFLDWHGZLWK+&9LQIHFWLRQLQLOOLFLWGUXJXVHUV
LQWKHPXQLFLSDOLW\RI%UHYHV6WDWHRI3DUiQRUWKHUQ%UD]LO
7KLVFURVVVHFWLRQDOVWXG\RIDQRQSUREDELOLVWLFFRQYHQLHQFH
VDPSOH ZDV EDVHG RQ LQIRUPDWLRQ DQG ELRORJLFDO VDPSOHV
SURYLGHGE\LOOLFLWGUXJXVHUVLQDQDUHDRILQWHQVHLOOLFLWGUXJ
XVHORFDWHGLQ%UHYHVƒ
6ƒ
2$UFKLSHODJR
RI0DUDMy3DUiQRUWKHUQ%UD]LO,OOLFLWGUXJXVHUVLQDUHDVRI
LQWHQVH GUXJ FRQVXPSWLRQ ZHUH VDPSOHG XVLQJ WKH VQRZEDOO
WHFKQLTXH11 ,QGLYLGXDOV ZHUH HOLJLEOH IRU WKH VWXG\ LI WKH\
ZHUHROGHUWKDQ\HDUVRIDJHDQGDJUHHGWRDQVZHUDVSHFL¿F
Address to: Dr. Aldemir Branco Oliveira-­Filho. Faculdade de Ciências Naturais, Instituto de Estudos Costeiros, Universidade Federal do Pará. Al. Leandro Ribeiro, s/n. Aldeia, 68600-­000 Bragança, Pará, Brasil. Phone: 55 91 3425-­1593;; Fax: 55 91 3425-­1209. e-­mail: ROLY¿OKR#XISDEU
Received 21 July 2013
Accepted 27 November 2013
TXHVWLRQQDLUH DQG KDYH D EORRG VDPSOH WDNHQ DQG WHVWHG IRU
PROHFXODUDQGVHURORJLFPDUNHUVLQWKHSHULRGIURP$XJXVWWR
'HFHPEHU7KH5HVHDUFKDQG (WKLFV&RPPLWWHHRI WKH
Núcleo de Medicina TropicalRIWKHUniversidade Federal do ParáDSSURYHGWKHVWXG\SURWRFRO&(3107
$OOVDPSOHVZHUHWHVWHGIRU+&9DQWLERGLHVDQGKHSDWLWLV&
YLUXVULERQXFOHLFDFLG+&951$$QWL+&9DQWLERGLHVZHUH
WHVWHG E\ HQ]\PH LPPXQRDVVD\ (,$ 0XUH[ DQWL+&9 0XUH[%LRWHFK+&951$ZDVGHWHFWHGE\UHDOWLPHSRO\PHUDVH
FKDLQUHDFWLRQ3&5XVLQJEDVHSDLUVRIWKH¶XQWUDQVODWHG
UHJLRQ 875 DV GHVFULEHG HOVHZKHUH9 &RQ¿GHQFH LQWHUYDOV
&,VZHUHGHWHUPLQHGIRULQIHFWLRQSUHYDOHQFHHVWLPDWHV6LPSOH
DQGPXOWLSOHORJLVWLFUHJUHVVLRQVZHUHFDOFXODWHGWRDVVHVVWKH
LQGHSHQGHQWHIIHFWVRIYDULDEOHV127KH¿WRIWKH¿QDOPRGHOZDV
DVVHVVHGXVLQJWKH+RVPHU/HPHVKRZJRRGQHVVRI¿WWHVW7ZR
GH¿QLWLRQVRI+&9LQIHFWLRQZHUHXVHG,DQWL+&9SRVLWLYLW\
VKRZQE\(,$DQG,,+&951$GHWHFWLRQE\UHDOWLPH3&5$OO
VWDWLVWLFDODQDO\VHVZHUHSHUIRUPHGXVLQJ,%063666WDWLVWLFV
,QWRWDOLOOLFLWGUXJXVHUVSDUWLFLSDWHGLQWKLVVWXG\7KH
PDMRULW\ RI SDUWLFLSDQWV ZHUH PDOH 7KH PHDQ DJH was 28.5 years (range, 18-­51 years;; standard deviation [SD] ± \HDUV7KHPDMRULW\RISDUWLFLSDQWVKDG!\HDUVRIHGXFDWLRQ
DQGEHORQJHGWRIDPLOLHVZLWKPRQWKO\LQFRPHVRIXS
to R$1,090.00 (US$545.00). Table 1VKRZVWKHGHPRJUDSKLF
DQGHSLGHPLRORJLFDOFKDUDFWHULVWLFVRIWKHSDUWLFLSDQWV,QWKLV
VWXG\ PRVW SDUWLFLSDQWV UHSRUWHG KDYLQJ FRQVXPHG
PRUHWKDQRQHLOOLFLWGUXJGXULQJWKHLUOLIHWLPHV7KXVLOOLFLWGUXJ
XVHUVZHUHJURXSHGDFFRUGLQJWRWKHPRVWIUHTXHQWO\XVHGGUXJ
'UXJ SUHIHUHQFH ZDV JURXSHG LQWR ¿YH FDWHJRULHV FDQQDELV
FRFDLQH SDVWH FDQQDELV DQG FRFDLQH SDVWH
FRFDLQH SRZGHU DQG R[L FRFDLQH Pacheco SDB et al -‐ HCV infection among illicit drug users in Breves
7$%/('HPRJUDSKLFDQGHSLGHPLRORJLFDOFKDUDFWHULVWLFVRILOOLFLWGUXJXVHUVLQWKHPXQLFLSDOLW\RI%UHYHV6WDWHRI3DUiQRUWKHUQ%UD]LO
2YHUDOOVDPSOH$QWL+&9
Characteristics +&951$
n % n % 7RWDO
0HDQDJH\HDUV
60 32.1 23 38.33 1.1 (0.6 -­ 2.1) 21 35.00 1.3 (0.7 -­ 2.5)
±
IDPLO\PHPEHUFORVHIULHQGLQIHFWHGZLWKKFY
UHFLSLHQWRIEORRGWUDQVIXVLRQ
10 43.5 1.4 (0.6 -­ 3.3) 8 34.8 1.2 (0.5 -­ 3.0)
surgery 89 47.6 36 40.4 1.3 (0.7 -­ 2.4) 31 34.8 1.4 (0.7 -­ 2.6)
tattoos 125 66.8 63 50.4 9.5 (3.8 -­ 23.6) 55 44.0 15.4 (4.6 -­ 41.9)
shares razor blades in domestic environment 65 34.7 26 40.0 1.2 (0.6 -­ 2.3) 21 32.3 1.1 (0.6 -­ 2.1)
VKDUHVUD]RUEODGHVLQEDUEHUVKRSEHDXW\VDORQ
uses needle/glass syringe sterilized at home 48 25.7 19 39.6 1.2 (0.6 -­ 2.3) 18 37.5 1.5 (0.7 -­ 3.0)
GRHVQRWXVHRZQQDLOFOLSSHUV
invasive dental treatment 150 80.2 54 36.0 0.8 (0.4 -­ 1.7) 45 30.0 0.8 (0.4 -­ 1.7)
VKDUHVSDUDSKHUQDOLDGXULQJGUXJXVH
XVHGGUXJVIRUPRUHWKDQWKUHH\HDUV
117 62.6 63 53.8 12.4 (5.0 -­ 31.0) 56 47.9 31.2 (7.3 -­ 65.4)
XVHGGUXJVGXULQJGHWHQWLRQLQMDLOSULVRQ
QRXVHRISURSK\ODFWLFGXULQJLQWHUFRXUVH
LQWHUFRXUVHZLWKDVH[ZRUNHU
VH[XDOLQWHUFRXUVHZLWKDQRWKHULOOLFLWGUXJXVHU
103 55.1 34 33.0 0.7 (0.4 -­ 1.2) 26 25.2 0.5 (0.3 -­ 1.0)
Age t 35 years 0DOH
OR (CI 95%) n % OR (CI 95%)
6XSSRVHGURXWHRI+&9LQIHFWLRQ
LQMHFWLQJGUXJXVH
daily drug use VDPHVH[LQWHUFRXUVH
LQYROYHPHQWLQSURVWLWXWLRQ
PRUHWKDQVH[XDOSDUWQHUVRYHUWKHSDVWWZR\HDUV 1RWH $ XQLYDULDWH DQDO\VLV FRPSDULQJ WKH JURXSV WKDW WHVWHG SRVLWLYH DQG QHJDWLYH IRU +&9 LV SUHVHQWHG WKURXJK RGGV UDWLRV DQG &,V +&951$KHSDWLWLV&YLUXV-­ribonucleic acid25RGGVUDWLR&,FRQ¿GHQFHLQWHUYDO
$OO XVHUV UHSRUWHG D SUHIHUHQFH IRU XVLQJ QRQLQMHFWHG LOOLFLW
GUXJV+RZHYHUXVHUVUHSRUWHGKDYLQJXVHGLQMHFWHG
LOOLFLWGUXJVDWOHDVWRQFH7REDFFRDQGDOFRKRO
ZHUHDOVRFRPPRQO\FRQVXPHGE\WKHVXEMHFWV
2I WKH LOOLFLW GUXJ XVHUV KDG DQWL+&9
DQWLERGLHV DQG KDG +&951$ 8VLQJ D VLPSOH
ORJLVWLF UHJUHVVLRQ DQDO\VLV +&9 LQIHFWLRQ ZDV DVVRFLDWHG
ZLWKWDWWRRVLQWUDYHQRXVGUXJXVHVKDUHGXVHRIHTXLSPHQWIRU
GUXJXVHGUXJXVHIRUORQJHUWKDQ\HDUVDQGGDLO\GUXJXVH (Table 1)$ PXOWLYDULDWH DQDO\VLV LGHQWL¿HG WKH VDPH ¿YH
ULVNIDFWRUVIRU+&9LQIHFWLRQIRUWKHWZRGLDJQRVWLFPHWKRGV
HPSOR\HG(Table 2)7KH+RVPHU/HPHVKRZJRRGQHVVRI¿W
WHVWVKRZHGDJRRG¿WIRU¿QDOPRGHO+/Ȥ2 S DQG
model 2 (+/Ȥ2 S ,OOLFLW GUXJ XVHUV DUH FXUUHQWO\ WKH PDLQ JURXS RI SHRSOH
LQIHFWHG ZLWK KHSDWLWLV & 1,13. It is well known that such LQGLYLGXDOV WHQG WR GHYHORS D FKURQLF LQIHFWLRQ XOWLPDWHO\
OHDGLQJ WR FKURQLF KHSDWLWLV 0DQ\ RI WKHVH LQGLYLGXDOV DUH
QRWFOLQLFDOO\LOODQGDUHWKHUHIRUHXQDZDUHRIWKHLULQIHFWLRQ
OHDGLQJWRDFWLYLWLHVWKDWFRQWULEXWHWRDQLQFUHDVHGLQFLGHQFHRI
+&92,157KHSUHYDOHQFHRI+&9LQIHFWLRQLQLOOLFLWGUXJXVHUV
YDULHV IURP WR UHÀHFWLQJ WKH SUHVHQFH RU DEVHQFH
RIVSHFL¿FULVNIDFWRUVVXFKDVKDYLQJDKLVWRU\RIGUXJXVH
VKDULQJ GUXJ SDUDSKHUQDOLD HJ QHHGOHV V\ULQJHV SLSHV
FDQVHWFWDWWRRLQJSLHUFLQJWKHERG\HDUVXVLQJGUXJVZKLOH
EHLQJ GHWDLQHG LQ MDLO RU SULVRQ DQG WKH QXPEHU RI SDUWQHUV
SUHVHQWGXULQJVKDUHGXVHDQGWKHPHWKRGRIGUXJFRQVXPSWLRQ (i.e., LQKDOHGRULQMHFWHG1,4,5,13,15.
Rev Soc Bras Med Trop
7$%/(5LVNIDFWRUVDVVRFLDWHGZLWK+&9LQIHFWLRQEDVHGRQPXOWLSOHORJLVWLFUHJUHVVLRQPRGHOV
0RGHO
5LVNIDFWRUV
0RGHO
25&,
SYDOXH
25&,
SYDOXH
7DWWRRV
,QMHFWLQJGUXJXVH
6KDULQJRISDUDSKHUQDOLDGXULQJGUXJXVH
'UXJXVHIRUPRUHWKDQWKUHH\HDUV
'DLO\GUXJXVH
+&9 LQIHFWLRQ EDVHG RQ (,$ PRGHO DQG 3&5 PRGHO UHVXOWV +&9 KHSDWLWLV & YLUXV 25 RGGV UDWLR &, FRQ¿GHQFH LQWHUYDO RQ(,$HQ]\PHLPPXQRDVVD\3&5SRO\PHUDVHFKDLQUHDFWLRQ
,Q 6DOYDGRU 6WDWH RI %DKLD QRUWKHDVWHUQ %UD]LO 7, the VHURSUHYDOHQFHRI+&9LQIHFWLRQGHWHFWHGLQLQMHFWHGGUXJXVHUV
ZDVVLPLODUWRWKDWREVHUYHGLQWKLVVWXG\1RWHWKDWPRVWRIWKH
VWXG\SDUWLFLSDQWVXVHQRQLQMHFWLQJLOOLFLWGUXJV7KHVSRUDGLF
XVHRILQMHFWDEOHLOOLFLWGUXJVVKDUHGHTXLSPHQWIRUGUXJXVHDQG
GDLO\GUXJXVHIRUPRUHWKDQWKUHH\HDUVPRVWOLNHO\FRQWULEXWH
VLJQL¿FDQWO\WRYLUDOWUDQVPLVVLRQDQGDKLJKSUHYDOHQFHRI+&9
LQIHFWLRQDPRQJLOOLFLWGUXJXVHUVLQWKHPXQLFLSDOLW\RI%UHYHV
$IHZVWXGLHV13,14KDYHUHSRUWHGWKHSUHVHQFHRI+&951$LQ
WKH QDVDO VHFUHWLRQV RI FRFDLQH DQG FUDFN XVHUV LQGLFDWLQJ D
SRVVLEOHDOWHUQDWLYHURXWHIRUYLUXVWUDQVPLVVLRQLHVKDULQJ
WKHSDUDSKHUQDOLDXVHGWRFRQVXPHWKHVHGUXJV
7KH IDFWRUV DVVRFLDWHG ZLWK +&9 LQIHFWLRQ GHWHFWHG LQ
LOOLFLW GUXJ XVHUV LQ %UHYHV DUH VLPLODU WR WKRVH UHSRUWHG LQ
HSLGHPLRORJLFDO VWXGLHV LQ GLIIHUHQW %UD]LOLDQ PXQLFLSDOLWLHV
IRUWKLVULVNJURXS3-­6,116SHFL¿FDOO\WKHULVNIDFWRUVIRU+&9
LQIHFWLRQDUHLGHQWLFDOWRWKRVHGHWHFWHGLQFRFDLQHXVHUVLQWKH
6WDWHRI3DUi11WKXVFRQ¿UPLQJWKHORFDOHSLGHPLRORJLFDOSUR¿OH
RI+&9WUDQVPLVVLRQLQLOOLFLWGUXJXVHUV,QVXPPDU\WKLVVWXG\
LGHQWL¿HGLPSRUWDQWHSLGHPLRORJLFDODVSHFWVRI+&9LQIHFWLRQLQ
LOOLFLWGUXJXVHUVLQWKHPXQLFLSDOLW\RI%UHYHV7KH¿QGLQJVFDQ
EHXVHGWRGHYHORSPHDVXUHVIRUFRQWUROOLQJDQGSUHYHQWLQJYLUDO
WUDQVPLVVLRQLQWKLVULVNJURXSDQGLQWKHJHQHUDOSRSXODWLRQ
ACKNOWLEDGMENTS
7KHDXWKRUVWKDQNWKHFRRUGLQDWRUVRIWKHFRPPXQLW\FHQWHUV
LQWKHGLIIHUHQWQHLJKERUKRRGVRIWKHPXQLFLSDOLW\RI%UHYHV
7KH\FRQWULEXWHGVLJQL¿FDQWO\WRWKHFROOHFWLRQRIVDPSOHVDQG
HSLGHPLRORJLFDOLQIRUPDWLRQIURPWKHLOOLFLWGUXJXVHUV
CONFLICT OF INTEREST
7KHDXWKRUVGHFODUHWKDWWKHUHLVQRFRQÀLFWRILQWHUHVW
FINANCIAL SUPPORT
6'% 3DFKHFR UHFHLYHG D VFKRODUVKLS IURP 3URJUDPD
Institucional de %ROVDVGH,QLFLDomR&LHQWt¿FDGD8QLYHUVLGDGH
Federal do Pará3,%,&3523(638)3$IRUWKHGHYHORSPHQW
RI WKLV UHVHDUFK 7KLV VWXG\ UHFHLYHG ¿QDQFLDO VXSSRUW IURP
Ministério da Saúde/Secretaria de Vigilância em Saúde06
696 &RQVHOKR 1DFLRQDO GH 'HVHQYROYLPHQWR &LHQWt¿FR H
Tecnológico (CNPQ), and Programa de Apoio ao Recém Doutor da Universidade Federal do Pará (PARD-­UFPA).
REFERENCES
1. $FHLMDV&5KRGHV7*OREDOHVWLPDWHVRISUHYDOHQFHRI+&9LQIHFWLRQ
DPRQJLQMHFWLQJGUXJXVHUV,QW-'UXJ3ROLF\
2. 0DUWLQV71DUFLVR6FKLDYRQ-/6FKLDYRQ//(SLGHPLRORJ\RIKHSDWLWLV
&YLUXVLQIHFWLRQ5HY$VVRF0HG%UDV
3. 2OLYHLUD0/+DFNHU0$2OLYHLUD6$7HOOHV352.0<RVKLGD&) HWDO7KH¿UVWVKRWWKHFRQWH[WRI¿UVWLQMHFWLRQRILOOLFLWGUXJVRQJRLQJ
LQMHFWLQJ SUDFWLFHV DQG KHSDWLWLV & LQIHFWLRQ LQ 5LR GH -DQHLUR %UD]LO Cad Saude Publica 2006;; 22:861-­870.
4. /RSHV &/5 7HOHV 6$ (VStULWR6DQWR 03 /DPSH ( 5RGULJXHV )3 0RWWD&DVWUR $5& HW DO 3UHYDOHQFH ULVN IDFWRUV DQG JHQRW\SHV RI
KHSDWLWLV & YLUXV LQIHFWLRQ DPRQJ GUXJ XVHUV &HQWUDO:HVWHUQ %UD]LO Rev Saude Publica 2009;; 43:S1-­S7.
5. 1RYDLV $&0 /RSHV &/5 5HLV 156 6LOYD $0& 0DUWLQV 50% 6RXWR)-'3UHYDOHQFHRIKHSDWLWLV&YLUXVLQIHFWLRQDQGDVVRFLDWHGIDFWRUV
DPRQJPDOHLOOLFLWGUXJXVHUVLQ&XLDEi0DWR*URVVR%UD]LO0HP,QVW
Oswaldo Cruz 2009;; 104:892-­896.
6. 2OLYHLUD 0/ %DVWRV ), 7HOOHV 35 +DFNHU 0$ 2OLYHLUD 6$1 0LJXHO -& HW DO (SLGHPLRORJLFDO DQG JHQHWLF DQDO\VHV RI +HSDWLWLV &
YLUXV WUDQVPLVVLRQ DPRQJ \RXQJVKRUW DQG ORQJWHUP LQMHFWLQJ GUXJ
XVHUVIURP5LRGH-DQHLUR%UD]LO-&OLQ9LURO
7. 6LOYD0%$QGUDGH706LOYD/.5RGDUW,)/RSHV*%&DUPR70$
HWDO3UHYDOHQFHDQGJHQRW\SHVRIKHSDWLWLV&YLUXVDPRQJLQMHFWLQJGUXJ
XVHUV IURP 6DOYDGRU%$ %UD]LO 0HP ,QVW 2VZDOGR &UX] 299-­303.
8. 7RUUHV./0DOKHLUR$7DWHQR$/LPD7$0DLD/393LPHQWHO-3'
HWDO+HSDWLWLV&YtUXVLQEORRGGRQRUV%UD]LO(PHUJ,QIHFW'LV
15:676-­678.
9. 2OLYHLUD)LOKR$%3LPHQWD$6&5RMDV0)0&KDJDV0&0&UHVSR'0 &UHVFHQWH-$%HWDO3UHYDOHQFHDQGJHQRW\SLQJRIKHSDWLWLVFYLUXVLQ
EORRG GRQRUV LQ WKH VWDWH RI 3DUi 1RUWKHUQ %UD]LO 0HP ,QVW 2VZDOGR
Cruz 2010;; 105:103-­106.
10. 6DZDGD/3LQKHLUR$&&/RFNV'3LPHQWD$6&5H]HQGH35&UHVSR'0 HWDO'LVWULEXWLRQRIKHSDWLWLV&YLUXVJHQRW\SHVDPRQJGLIIHUHQWH[SRVXUH
FDWHJRULHV LQ WKH 6WDWH RI 3DUi %UD]LOLDQ$PD]RQ 5HY 6RF %UDV 0HG
7URS
Pacheco SDB et al -‐ HCV infection among illicit drug users in Breves
11. Oliveira-­Filho AB, Sawada L, Pinto LC, Locks D, Bahia SL, Brasil-­Costa I, HWDO+&9LQIHFWLRQDPRQJFRFDLQHXVHUVLQWKHVWDWHRI3DUi%UD]LOLDQ
$PD]RQ$UFK9LURO
14. $DURQ 6 0F0DKRQ -0 0LODQR ' 7RUUHV / &ODWWV 0 7RUWX 6 HW DO
,QWUDQDVDO 7UDQVPLVVLRQ RI +HSDWLWLV & 9LUXV 9LURORJLFDO DQG &OLQLFDO
(YLGHQFH&OLQ,QIHFW'LV
12. 2OLYHLUD)LOKR$%3LPHQWD$6&5RMDV0)0&KDJDV0&0&UHVSR'0 &UHVFHQWH -$% HW DO /LNHO\ WUDQVPLVVLRQ RI KHSDWLWLV & YLUXV WKURXJK
VKDULQJ RI FXWWLQJ DQG SHUIRUDWLQJ LQVWUXPHQWV LQ EORRG GRQRUV LQ WKH 6WDWHRI3DUi1RUWKHUQ%UD]LO&DG6DXGH3XEOLFD
15. 7H+6-HQVHQ'0(SLGHPLRORJ\RIKHSDWLWLV%DQG&YLUXVHVDJOREDO
overview. Clin Liver Dis 2010;;14:1-­21.
13. 6FKHLQPDQQ5+DJDQ+/HOXWLX:HLQEHUJHU&6WHUQ5'HV-DUODLV'&
)ORP3/HWDO1RQLQMHFWLRQGUXJXVHDQG+HSDWLWLV&9LUXVDV\VWHPDWLF
UHYLHZ'UXJ$OFRKRO'HSHQG